Overview

APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of APC 111 MP Tablet, 775 mg tablet, given orally (PO)once daily (QD) for 10 days compared to that of Penicillin VK, 250 mg PO four times daily (QID) for 10 days in terms of bacteriological outcome at the Test-of-Cure (TOC) Visit (Day 14-18) in the eligible Per-Protocol bacteriological (PPb) population.
Phase:
Phase 3
Details
Lead Sponsor:
Advancis Pharmaceutical Corporation
Treatments:
Penicillin V
Penicillins